KNUST
KNUST

KNUST, School of Public Health gain approval to Trial Potential Treatment of Covid-19, nanansem.com can report.

The Kwame Nkrumah University of Science and Technology, School of Public health has gained the approval of their Trial Potential Treatment for Covid-19.

Advertisement

The approval of this Trial Potential Treatment was given to these researchers by the Ghana Food and Drugs Authority (FDA) and the National Medicine Regulatory Agency (NMRA) locally known as Nibima, Kadze and Gangamu.

The FDA in a press release said the approval follows “results from laboratory studies conducted by the KNUST research team which points in the direction of possible clinical benefits”.

“The Food and Drugs Authority (FDA), the National Medicine Regulatory Agency (NMRA) in Ghana, has approved a herbal medicine, Cryptolepis sanguinolenta, locally known as Nibima for clinical trials in January 2021,” the release said.

“In search for a treatment for the ongoing COVID-19 pandemic researchers from the School of Public Health at the Kwame Nkrumah University of Science and Technology (KNUST), submitted a clinical trial application in September 2020 to assess the safety and efficacy of Cryptolepis sanguinolenta as a potential treatment for Covid-19. This follows results from laboratory studies conducted by the KNUST research team which points in the direction of possible clinical benefits”.

Advertisement